Filing and business context
LRAD Corporation (the registrant named in this 10-Q; the request identifies Genasys Inc.) filed for the fiscal quarter ended March 31, 2015, its second fiscal quarter, and reported six-month results for the period ended that date. The company develops and sells directed and omnidirectional long-range acoustic and mass-notification products. Interim results are unaudited.
Key financial results
| Metric | Three months ended March 31, 2015 | Prior-year quarter | Six months ended March 31, 2015 | Prior-year six months |
|---|---|---|---|---|
| Revenue | $4.49 million | $5.39 million | $8.87 million | $9.21 million |
| Gross profit / margin | $2.30 million / 51.2% | $2.73 million / 50.7% | $4.66 million / 52.5% | $4.67 million / 50.7% |
| Operating income / margin | $261,190 / 5.8% | $522,440 / 9.7% | $740,621 / 8.4% | $648,906 / 7.0% |
| Net income | $290,511 | $525,926 | $796,145 | $657,489 |
| Diluted earnings per share | $0.01 | $0.02 | $0.02 | $0.02 |
- Operating cash flow was $21,773 for the six months, compared with $2.99 million in the prior-year period. Investing cash flow was negative $4.72 million, primarily reflecting $4.54 million of marketable-security purchases; financing cash flow was negative $51,526.
- Cash and cash equivalents were $19.15 million at March 31, 2015, down from $23.89 million at September 30, 2014. Short- and long-term marketable securities totaled $4.55 million. The filing reports no debt.
- Current assets were $28.50 million and current liabilities $2.53 million; working capital was $25.96 million. Stockholders’ equity was $29.76 million.
Changes versus comparable periods
- Quarterly revenue fell 16.7% year over year, primarily because of order timing; net income declined 44.8%. Operating expenses decreased 7.8%, but the revenue decline reduced operating income by half.
- Six-month revenue declined 3.7%, while net income increased 21.1%. Improved gross margin percentage, lower operating expenses overall, and higher other income offset the lower revenue. Research and development expense rose 8.0% over the six-month period.
- Quarterly gross margin improved to 51.2% from 50.7%, and six-month gross margin to 52.5% from 50.7%, with management citing favorable product mix.
- Cash declined as the company invested in securities and paid down accrued liabilities, including fiscal 2014 bonuses. Receivables fell to $2.35 million from $4.28 million at September 30, 2014, while inventory increased to $4.56 million from $3.90 million.
Outlook, risks, and notable items
- Management expected the second half of fiscal 2015 to be much stronger than the first half, while warning that quarterly revenue would remain uneven due to customer budgets, approvals, and contract timing. No specific revenue or earnings guidance was provided.
- Management expected research and development spending for the remainder of fiscal 2015 to be comparable to the prior year. It planned continued international selling efforts, including in the Middle East and South America, and further development of the omnidirectional mass-notification business.
- Risks discussed include geopolitical and economic conditions, uncertainty and reductions in U.S. military spending, lengthy or unsuccessful sales cycles, competition in mass notification, product acceptance, sales mix and margins, inventory levels, and potential capital needs. Management believed available capital was sufficient for at least twelve months under planned spending and operations, but noted future funding might be needed and might not be available on acceptable terms.
- Three customers represented 21%, 17%, and 15% of quarterly revenue; three customers represented 34%, 19%, and 11% of accounts receivable at quarter-end. This creates customer concentration exposure.
- The company had federal and state net operating loss carryforwards and a full valuation allowance against deferred tax assets. It reported no pending material legal proceedings. Disclosure controls were assessed as effective, with no material change in internal control over financial reporting reported for the quarter.
- The company repurchased 69,213 shares during the quarter at an average $2.29 per share. Its buyback authorization, up to $4 million in aggregate, was extended through December 31, 2015.
Most important facts for investors to verify
- Confirm the registrant identity and ticker: this source is a 2015 LRAD Corporation 10-Q, notwithstanding the request’s Genasys Inc. label.
- Track whether the anticipated second-half improvement materialized and whether uneven order timing continues to affect revenue.
- Assess conversion of reported earnings into operating cash flow, particularly the impact of accrued-liability payments, inventory investment, and customer collections.
- Monitor customer concentration, U.S. defense-budget exposure, and adoption of the omnidirectional product line in a competitive market.
- Review future liquidity and capital needs, product-mix effects on margins, and potential dilution from outstanding options and warrants.